TY - JOUR AU - Jemal, A. AU - Bray, F. AU - Center, M. M. AU - Ferlay, J. AU - Ward, E. AU - Forman, D. PY - 2011 DA - 2011// TI - Global cancer statistics JO - CA Cancer J Clin VL - 61 UR - https://doi.org/10.3322/caac.20107 DO - 10.3322/caac.20107 ID - Jemal2011 ER - TY - STD TI - UK CR. Bladder cancer statistics. [cited 2014 16/04/2014]; Available from: http://www.cancerresearchuk.org/cancer-info/cancerstats/types/bladder/ UR - http://www.cancerresearchuk.org/cancer-info/cancerstats/types/bladder/ ID - ref2 ER - TY - JOUR PY - 2013 DA - 2013// TI - Cancer survival and prevalence in Australia: period estimates from 1982 to 2010 JO - Asia Pac J Clin Oncol VL - 9 UR - https://doi.org/10.1111/ajco.12062 DO - 10.1111/ajco.12062 ID - ref3 ER - TY - BOOK AU - Babjuk, M. AU - Burger, M. AU - Zigeuner, R. AU - Shariat, S. AU - Rhijn, B. AU - Compérat, E. PY - 2013 DA - 2013// TI - European Association of Urology guidelines on non-muscle-invasive bladder cancer (TaT1 and CIS) ID - Babjuk2013 ER - TY - JOUR AU - Sylvester, R. J. AU - Meijden, A. P. AU - Oosterlinck, W. AU - Witjes, J. A. AU - Bouffioux, C. AU - Denis, L. PY - 2006 DA - 2006// TI - Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials JO - Eur Urol VL - 49 UR - https://doi.org/10.1016/j.eururo.2005.12.031 DO - 10.1016/j.eururo.2005.12.031 ID - Sylvester2006 ER - TY - STD TI - SEER Cancer Statistics Factsheets: Bladder Cancer. National Cancer Institute. [cited 2014 16/04/2014]; Available from: http://seer.cancer.gov/statfacts/html/urinb.html UR - http://seer.cancer.gov/statfacts/html/urinb.html ID - ref6 ER - TY - JOUR AU - Shelley, M. D. AU - Kynaston, H. AU - Court, J. AU - Wilt, T. J. AU - Coles, B. AU - Burgon, K. PY - 2001 DA - 2001// TI - A systematic review of intravesical bacillus Calmette-Guerin plus transurethral resection vs transurethral resection alone in Ta and T1 bladder cancer JO - BJU Int VL - 88 UR - https://doi.org/10.1046/j.1464-410x.2001.02306.x DO - 10.1046/j.1464-410x.2001.02306.x ID - Shelley2001 ER - TY - JOUR AU - Sylvester, R. J. AU - Meijden, A. P. AU - Lamm, D. L. PY - 2002 DA - 2002// TI - Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials JO - J Urol VL - 168 UR - https://doi.org/10.1016/S0022-5347(05)64273-5 DO - 10.1016/S0022-5347(05)64273-5 ID - Sylvester2002 ER - TY - JOUR AU - Hall, M. C. AU - Chang, S. S. AU - Dalbagni, G. AU - Pruthi, R. S. AU - Seigne, J. D. AU - Skinner, E. C. PY - 2007 DA - 2007// TI - Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update JO - J Urol VL - 178 UR - https://doi.org/10.1016/j.juro.2007.09.003 DO - 10.1016/j.juro.2007.09.003 ID - Hall2007 ER - TY - JOUR AU - Zlotta, A. R. AU - Fleshner, N. E. AU - Jewett, M. A. PY - 2009 DA - 2009// TI - The management of BCG failure in non-muscle-invasive bladder cancer: an update. Canadian Urological Association journal = JO - Journal de l’Association des urologues du Canada VL - 3 ID - Zlotta2009 ER - TY - JOUR AU - Tolley, D. A. AU - Parmar, M. K. AU - Grigor, K. M. AU - Lallemand, G. AU - Benyon, L. L. AU - Fellows, J. PY - 1996 DA - 1996// TI - The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: a further report with 7 years of follow up JO - J Urol VL - 155 UR - https://doi.org/10.1016/S0022-5347(01)66226-8 DO - 10.1016/S0022-5347(01)66226-8 ID - Tolley1996 ER - TY - JOUR AU - Pawinski, A. AU - Sylvester, R. AU - Kurth, K. H. AU - Bouffioux, C. AU - Meijden, A. AU - Parmar, M. K. ,. K. PY - 1996 DA - 1996// TI - A combined analysis of European Organization for Research and Treatment of Cancer, and Medical Research Council randomized clinical trials for the prophylactic treatment of stage TaT1 bladder cancer. European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council Working Party on Superficial Bladder Cancer JO - J Urol VL - 156 UR - https://doi.org/10.1016/S0022-5347(01)65396-5 DO - 10.1016/S0022-5347(01)65396-5 ID - Pawinski1996 ER - TY - JOUR AU - Houghton, B. B. AU - Chalasani, V. AU - Hayne, D. AU - Grimison, P. AU - Brown, C. S. AU - Patel, M. PY - 2013 DA - 2013// TI - Intravesical chemotherapy plus bacille Calmette-Guerin in non-muscle invasive bladder cancer: a systematic review with meta-analysis JO - BJU Int VL - 111 UR - https://doi.org/10.1111/j.1464-410X.2012.11390.x DO - 10.1111/j.1464-410X.2012.11390.x ID - Houghton2013 ER - TY - JOUR AU - Stasi, S. M. AU - Giannantoni, A. AU - Giurioli, A. AU - Valenti, M. AU - Zampa, G. AU - Storti, L. PY - 2006 DA - 2006// TI - Sequential BCG and electromotive mitomycin versus BCG alone for high-risk superficial bladder cancer: a randomised controlled trial JO - Lancet Oncol VL - 7 UR - https://doi.org/10.1016/S1470-2045(05)70472-1 DO - 10.1016/S1470-2045(05)70472-1 ID - Stasi2006 ER - TY - JOUR AU - Hayne, D. AU - Stockler, M. AU - Ives, A. AU - Houghton, B. B. AU - Braganza, P. AU - Chalasani, V. PY - 2011 DA - 2011// TI - Sequential BCG and mitomycin intravesical therapy versus BCG alone for high-risk non-muscle invasive bladder cancer (NMIBC): pilot study and proposal for a 2-stage randomised phase III trial JO - BJU Int VL - 107 ID - Hayne2011 ER - TY - JOUR AU - Barry, M. J. AU - Fowler, F. J. AU - O’Leary, M. P. AU - Bruskewitz, R. C. AU - Holtgrewe, H. L. AU - Mebust, W. K. PY - 1992 DA - 1992// TI - The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association JO - J Urol VL - 148 ID - Barry1992 ER - TY - JOUR AU - O’Leary, M. P. AU - Sant, G. R. AU - Fowler, F. J. AU - Whitmore, K. E. AU - Spolarich-Kroll, J. PY - 1997 DA - 1997// TI - The interstitial cystitis symptom index and problem index JO - Urology VL - 49 UR - https://doi.org/10.1016/S0090-4295(99)80333-1 DO - 10.1016/S0090-4295(99)80333-1 ID - O’Leary1997 ER - TY - JOUR AU - Oken, M. M. AU - Creech, R. H. AU - Tormey, D. C. AU - Horton, J. AU - Davis, T. E. AU - McFadden, E. T. PY - 1982 DA - 1982// TI - Toxicity and response criteria of the Eastern Cooperative Oncology Group JO - Am J Clin Oncol VL - 5 UR - https://doi.org/10.1097/00000421-198212000-00014 DO - 10.1097/00000421-198212000-00014 ID - Oken1982 ER - TY - STD TI - EORTC Quality of Life Module for Bladder Cancer - Urinary Symptoms. [cited 21 March, 2011]; Available from: http://groups.eortc.be/qol/bladder-cancer-eortc-qlq-bls24-eortc-qlq-blm30 UR - http://groups.eortc.be/qol/bladder-cancer-eortc-qlq-bls24-eortc-qlq-blm30 ID - ref19 ER - TY - JOUR AU - Aaronson, N. K. AU - Ahmedzai, S. AU - Bergman, B. AU - Bullinger, M. AU - Cull, A. AU - Duez, N. J. PY - 1993 DA - 1993// TI - The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology JO - J Natl Cancer Inst VL - 85 UR - https://doi.org/10.1093/jnci/85.5.365 DO - 10.1093/jnci/85.5.365 ID - Aaronson1993 ER -